Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

234.56
+4.061.76%
Post-market: 234.560.00000.00%18:18 EDT
Volume:601.35K
Turnover:140.34M
Market Cap:30.37B
PE:-107.64
High:235.12
Open:230.48
Low:228.96
Close:230.50
Loading ...
Apr 05, 2022

Major Issues Report

8-K - Current report
Apr 04, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Major Issues Report

8-K - Current report
Feb 10, 2022

Major Issues Report

8-K - Current report
Feb 10, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Major Issues Report

8-K - Current report
Dec 20, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 29, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 16, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 09, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 09, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 03, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report